Ferring Pharmaceuticals Receives FDA Approval for Growth Hormone Name Change, Acquires ZOMACTON™ [somatropin (rDNA origin)] for Injection and Needle-Free Device in the U.S.
Ferring Enters U.S. Pediatric Endocrinology Market with Acquisition from Teva Pharmaceutical Industries Ltd. PARSIPPANY, N.J., March 31, 2015 – Ferring…